Assessment of Concordance between 22C3 and SP142 Immunohistochemistry Assays regarding PD-L1 Expression in Non-Small Cell Lung Cancer

Different anti-PD-1 and anti-PD-L1 antibodies bind different epitopes. However, whether the results from the SP142 and 22C3 immunochemistry (IHC) assays can be interchanged to determine patient eligibility for immunotherapy remains largely unknown. Histologic sections from 135 tumor samples were pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Haipeng, Lin, Gen, Huang, Cheng, Zhu, Weifeng, Miao, Qian, Fan, Xirong, Wu, Biao, Zheng, Xiaobing, Lin, Xiandong, Jiang, Kan, Hu, Dan, Li, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717240/
https://www.ncbi.nlm.nih.gov/pubmed/29209070
http://dx.doi.org/10.1038/s41598-017-17034-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717240/
https://www.ncbi.nlm.nih.gov/pubmed/29209070
http://dx.doi.org/10.1038/s41598-017-17034-5

Ejemplares similares